# Starfighters Space, Inc.: financial statements, quarterly

FJET · NYSE · CIK 1947016 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fjet.md) · [Financials](/companies/fjet/financials.md) · [Filings](/companies/fjet/filings.md) · [Insiders](/companies/fjet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fjet/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [0.0](/filings/0001062993-26-003744.md) | not reported | not reported | not reported | [0.0](/filings/0001062993-26-003744.md) | not reported |
| Research and development | $m | [0.0](/filings/0001062993-26-000429.md) | [0.0 d](/filings/0001062993-26-003746.md) | [0.3](/filings/0001062993-26-003744.md) | [0.2](/filings/0001062993-26-004518.md) | [0.2](/filings/0001062993-26-000429.md) | [0.4 d](/filings/0001062993-26-003746.md) | [0.1](/filings/0001062993-26-003744.md) | [0.0](/filings/0001062993-26-004518.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | [2.0](/filings/0001062993-26-004518.md) | not reported | not reported | not reported | [6.4](/filings/0001062993-26-004518.md) |
| Operating income | $m | not reported | not reported | not reported | [(2.2)](/filings/0001062993-26-004518.md) | not reported | not reported | not reported | [(11.6)](/filings/0001062993-26-004518.md) |
| Interest expense | $m | [0.1](/filings/0001062993-26-000429.md) | [0.1 d](/filings/0001062993-26-003746.md) | [0.1](/filings/0001062993-26-003744.md) | [0.2](/filings/0001062993-26-004518.md) | [0.2](/filings/0001062993-26-000429.md) | [0.1 d](/filings/0001062993-26-003746.md) | [0.0](/filings/0001062993-26-003744.md) | [0.0](/filings/0001062993-26-004518.md) |
| Net income | $m | [(2.4)](/filings/0001062993-26-000429.md) | [(0.6) d](/filings/0001062993-26-003746.md) | [(2.7)](/filings/0001062993-26-003744.md) | [(1.9)](/filings/0001062993-26-004518.md) | [(2.0)](/filings/0001062993-26-000429.md) | [(10.3) d](/filings/0001062993-26-003746.md) | [(4.3)](/filings/0001062993-26-003744.md) | [(11.5)](/filings/0001062993-26-004518.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001062993-26-000429.md) | not reported | [(0.13)](/filings/0001062993-26-003744.md) | [(0.09)](/filings/0001062993-26-004518.md) | [(0.09)](/filings/0001062993-26-000429.md) | not reported | [(0.10)](/filings/0001062993-26-003744.md) | [(0.24)](/filings/0001062993-26-004518.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001062993-26-000429.md) | not reported | [(0.13)](/filings/0001062993-26-003744.md) | [(0.09)](/filings/0001062993-26-004518.md) | [(0.09)](/filings/0001062993-26-000429.md) | not reported | [(0.10)](/filings/0001062993-26-003744.md) | [(0.24)](/filings/0001062993-26-004518.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [3.8](/filings/0001062993-26-000429.md) | [7.1](/filings/0001062993-26-003746.md) | [4.0](/filings/0001062993-26-003744.md) | [3.8](/filings/0001062993-26-004518.md) | [2.6](/filings/0001062993-26-000429.md) | [4.6](/filings/0001062993-26-003746.md) | [1.4](/filings/0001062993-26-003744.md) | [1.5](/filings/0001062993-26-004518.md) |
| Current assets | $m | not reported | not reported | not reported | [8.4](/filings/0001062993-26-003746.md) | not reported | not reported | [4.5](/filings/0001062993-26-000429.md) | [20.1](/filings/0001062993-26-004518.md) | [18.2](/filings/0001062993-26-003744.md) | [28.1](/filings/0001062993-26-004518.md) |
| Total assets | $m | not reported | not reported | not reported | [10.3](/filings/0001062993-26-003746.md) | [12.6](/filings/0001062993-26-003744.md) | not reported | [12.2](/filings/0001062993-26-000429.md) | [28.4](/filings/0001062993-26-004518.md) | [26.3](/filings/0001062993-26-003744.md) | [32.5](/filings/0001062993-26-004518.md) |
| Current liabilities | $m | not reported | not reported | not reported | [16.0](/filings/0001062993-26-003746.md) | not reported | not reported | [17.6](/filings/0001062993-26-000429.md) | [3.1](/filings/0001062993-26-004518.md) | [3.5](/filings/0001062993-26-003744.md) | [2.4](/filings/0001062993-26-004518.md) |
| Total liabilities | $m | not reported | not reported | not reported | [16.2](/filings/0001062993-26-003746.md) | not reported | not reported | [17.7](/filings/0001062993-26-000429.md) | [3.5](/filings/0001062993-26-004518.md) | [3.9](/filings/0001062993-26-003744.md) | [2.8](/filings/0001062993-26-004518.md) |
| Shareholders' equity | $m | [(7.9)](/filings/0001062993-26-003746.md) | [(12.8)](/filings/0001062993-26-000429.md) | [(11.3)](/filings/0001062993-26-000429.md) | [(5.9)](/filings/0001062993-26-003746.md) | [(4.5)](/filings/0001062993-26-004518.md) | [(3.9)](/filings/0001062993-26-004518.md) | [(5.5)](/filings/0001062993-26-000429.md) | [24.9](/filings/0001062993-26-004518.md) | [22.4](/filings/0001062993-26-003744.md) | [29.8](/filings/0001062993-26-004518.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,860) d](/filings/0001062993-26-003746.md) | [(1,670)](/filings/0001062993-26-003744.md) | [(1,819) d](/filings/0001062993-26-004518.md) | [(1,504) d](/filings/0001062993-26-000429.md) | [(3,235) d](/filings/0001062993-26-003746.md) | [(3,964)](/filings/0001062993-26-003744.md) | [(6,097) d](/filings/0001062993-26-004518.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.7](/filings/0001062993-26-000429.md) | [19.7](/filings/0001062993-26-003744.md) | [21.0](/filings/0001062993-26-004518.md) | [21.6](/filings/0001062993-26-000429.md) | [44.0](/filings/0001062993-26-003744.md) | [47.0](/filings/0001062993-26-004518.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,996,019 at 2026-08-14, from the cover of the [10-Q filed 2026-08-19](/filings/0001062993-26-004518.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.